NiaMIT Continuation With Early-stage Mitochondrial Myopathy Patients

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 11, 2019

Primary Completion Date

September 18, 2020

Study Completion Date

September 18, 2020

Conditions
Mitochondrial Myopathies
Interventions
DIETARY_SUPPLEMENT

Niacin

The dose for a slow-released form of niacin will be 500-1000 mg/day. The daily niacin dose, 250 mg/day, is gradually escalated by 250 mg/month so that the full dose is reached after 2 months. The intervention time with the full niacin dose is 8 months and subsequently total intervention time 10 months.

Trial Locations (1)

Unknown

University of Helsinki, Helsinki

Sponsors
All Listed Sponsors
collaborator

Helsinki University Central Hospital

OTHER

collaborator

Institute for Molecular Medicine

OTHER

lead

University of Helsinki

OTHER